![Sven-Erik Svehag](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sven-Erik Svehag
Corporate Officer/Principal chez University of Southern Denmark
Postes actifs de Sven-Erik Svehag
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Southern Denmark | Corporate Officer/Principal | - | - |
World Health Organization
![]() World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | - | - |
National Bact. Laboratory | Corporate Officer/Principal | 14/08/2009 | - |
Historique de carrière de Sven-Erik Svehag
Anciens postes connus de Sven-Erik Svehag
Sociétés | Poste | Début | Fin |
---|---|---|---|
Profylakse ApS
![]() Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Directeur Général | - | 22/11/2013 |
Scandinavian Society of Immunology | President | - | - |
Statistiques
Internationale
Danemark | 4 |
Suisse | 2 |
Suède | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
President | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Government | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Profylakse ApS
![]() Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Health Technology |
World Health Organization
![]() World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Government |
Scandinavian Society of Immunology | |
National Bact. Laboratory |
- Bourse
- Insiders
- Sven-Erik Svehag
- Expérience